← FDA DRUG APPROVALS

FDA ANDA · ANDA077577

ONDANSETRON HYDROCHLORIDE

Sponsor: WOCKHARDT BIO AG

APPLICATION
ANDA077577
TYPE
ANDA
ORIGINAL APPROVAL
2006-12-26
LATEST ACTION
2023-04-19
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

ONDANSETRON HYDROCHLORIDEPrescription
ONDANSETRON HYDROCHLORIDE EQ 2MG BASE/ML · INJECTABLE · INJECTION

Approval history

2023-04-19Labeling · Supplement 4 · standardAP
2023-04-19Labeling · Supplement 5 · standardAP
2015-03-09Labeling · Supplement 3 · standardAP
2013-12-14Labeling · Supplement 1 · standardAP
2006-12-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →